Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Arch Gynecol Obstet. 2022 Oct;306(4):1299-1311. doi: 10.1007/s00404-022-06672-4. Epub 2022 Jul 24.
Despite its clinical success rates, transplantation after ovarian tissue cryopreservation (OTC) remains a matter of concern. Certain cancer subtypes may lead to the transfer of malignant cells when transplantation of affected ovarian tissue is conducted. IVG and subsequent isolation of vital follicles obtained from frozen thawed ovarian tissue for further in vitro maturation (IVM) would expand current fertility protection techniques while reducing the risk of retransplanting malignant cells.
A total of 216 cortical biopsies from 3 patients were included in this study in 4 treatment groups. After freezing, thawing and 8 days of hypoxic tissue culture supplemented with different concentrations of human follicular fluid (HuFF) and follicle-stimulating hormone (FSH), follicles were isolated enzymatically and stained with calcein to determine follicular viability. Numbers and size of vital follicles were assessed by fluorescence microscopy (Ti2, Nikon) and specified by computer assisted, semi-automated measurement (NIS software, Nikon). To estimate the effect of in vitro culture on apoptosis, tissue sections were stained for nicked DNA (TUNEL) prior and after tissue culture.
Analysing 3025 vital follicles, we observed significant differences [P < 0.01] regarding follicle size when hypoxic tissue culture was supplemented with HuFF compared with the control group on day 1, individual follicles reached sizes > 100 µm.
The results implicate that HuFF contains valuable factors contributing to significant IVG of follicles in human ovarian tissue and could be regarded as an additional tool in personalized fertility restoration prior to retransplantation of ovarian tissue.
尽管卵巢组织冷冻保存(OTC)后的移植成功率较高,但仍存在一些问题。在进行受影响的卵巢组织移植时,某些癌症亚型可能会导致恶性细胞转移。免疫球蛋白 G(IVG)和随后从冷冻解冻的卵巢组织中分离出有活力的卵泡进行进一步的体外成熟(IVM),将扩大当前的生育保护技术,同时降低重新移植恶性细胞的风险。
本研究共纳入 3 名患者的 216 个皮质活检标本,分为 4 个治疗组。冷冻、解冻后,在缺氧组织培养中添加不同浓度的人卵泡液(HuFF)和卵泡刺激素(FSH)8 天,然后用酶法分离卵泡,并以钙黄绿素染色以确定卵泡活力。通过荧光显微镜(Ti2,Nikon)评估有活力的卵泡数量和大小,并通过计算机辅助、半自动测量(NIS 软件,Nikon)指定。为了评估体外培养对细胞凋亡的影响,在组织培养前后对组织切片进行了切口 DNA(TUNEL)染色。
分析 3025 个有活力的卵泡,我们观察到,在缺氧组织培养中添加 HuFF 与对照组相比,第 1 天卵泡大小有显著差异[P < 0.01],单个卵泡大小> 100 µm。
这些结果表明,HuFF 中含有有价值的因子,有助于人类卵巢组织中卵泡的显著 IVG,并可被视为卵巢组织重新移植前个性化生育恢复的附加工具。